Verseon Corp (LSE:VSN) - Share price - Overview

Stock Report

Verseon Corp VSN

Last Price
GBX120.00

Day Change
0.00|0.00%

As of 19/01/2018
16:11:40 GMT | GBX
Minimum 15 Minutes Delay.

Last Close120.00p
Day Range123.00 - 123.00
Mkt Cap181.80Mil
52-Wk Range119.50 - 165.00
Yield %0.00
ISINUSU9221J1098
Volume2,510
P/E-12.46
P/SInfinity
P/CF-15.19

Share Price

Total Returns 19/01/2018

 Chg (%)  
More ...
Verseon Corp-1.23 
FTSE 100 TR GBP2.61
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-4.79-6.38-12.84
Net Profit-4.98-5.04-14.44
Reported EPS-3.04-3.93-9.63
Balance Sheet
Current Assets0.0350.7838.23
Non Current Assets0.057.3518.07
Total Assets0.0858.1356.30
Current Liabilities1.581.243.74
Total Liabilities2.871.243.74
Total Equity-2.7956.8952.56
Cash Flow
Operating Cash Flow-2.10-6.32-11.96
Net Change in Cash0.0026.10-7.35
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-18.51-12.36--9.71---
2018-11.381.70-70.63---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
05/01/2018Transfer inDr. Thomas Hecht0.0018,0720.00
05/01/2018Transfer inDr. Robert Karr0.006,0240.00
05/05/2017Transfer inDr. Thomas Hecht0.007,0100.00
05/05/2017Transfer inMr. Grover Wickersham0.007,7320.00

Company Profile

Verseon Corp is a pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates which are aimed at the treatment of unmet diseases.

Sector

Biotechnology

Market Position

750 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(25/09/2017) ceo - "...we are well-positioned to further grow shareholder value"

Next Event 13/03/2018

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)70.6314.145.53
Div Yld (E)0.004.064.03
PEG (E)0.00-0.460.98
ROCE-27.46179.53180.33
Op Mrgn0.00-8.37-126.27
EPS Grwth0.005.7922.39
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Thomas Hecht
Chief Executive OfficerMr. Adityo Prakash
Chief Operating Officer, Chief FinancialMs. Eniko Fodor
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.